NeoGenomics
119 hedge funds and large institutions have $382M invested in NeoGenomics in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 15 closing their positions.
470% more call options, than puts
Call options by funds: $907K | Put options by funds: $159K
41% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 32
0% more funds holding
Funds holding: 119 → 119 (0)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
12% less capital invested
Capital invested by funds: $435M → $382M (-$53.2M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$2.29M |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$2.27M |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$2M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
+$1.83M |
| 5 |
Morgan Stanley
New York
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$2.06M |
| 2 |
Millennium Management
New York
|
-$1.52M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.17M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.12M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$934K |
NEO Hedge Fund Activity: Q1 2016 in Review
119 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2016, worth a combined $382M — down 12% from $435M a quarter earlier.
Fund positioning in NEO was balanced in Q1 2016: 15 funds opened new positions, 15 closed out, 45 added to existing stakes and 32 trimmed.
The largest buyer was Royce & Associates, adding an estimated $2.29M. The largest seller was William Blair & Company, cutting an estimated $2.06M.
- 119 institutional investors held NeoGenomics (NEO) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $382M of NeoGenomics stock for Q1 2016, down 12% quarter-over-quarter.
- 15 funds opened new NeoGenomics positions in Q1 2016 and 15 closed out, a net change of 0 holders.
- The largest NeoGenomics buyer in Q1 2016 was Royce & Associates, an estimated $2.29M added.
- The largest NeoGenomics seller in Q1 2016 was William Blair & Company, an estimated $2.06M sold.
Based on aggregated 13F filings for Q1 2016.